Click for best price
Antiobesity Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 63090 million
|
Forecast Market size by 2030 |
US$ 83320 million
|
| Growth Rate |
CAGR of 4.0% |
Number of Pages |
120 Pages |
This research report provides a comprehensive analysis of the Anti-obesity Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Anti-obesity Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Anti-obesity Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Anti-obesity Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Anti-obesity Drugs market presents opportunities for various stakeholders, including Kids, Adults. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Anti-obesity Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Anti-obesity Drugs market was valued at US$ 63090 million in 2023 and is projected to reach US$ 83320 million by 2030, at a CAGR of 4.0% during the forecast period.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
Key Features:
The research report on the Anti-obesity Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Anti-obesity Drugs market.
Market Overview: The report provides a comprehensive overview of the Anti-obesity Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Peripherally Acting Anti-obesity Drugs, Centrally Acting Anti-obesity Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Anti-obesity Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Anti-obesity Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Anti-obesity Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Anti-obesity Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Anti-obesity Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Anti-obesity Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Anti-obesity Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Anti-obesity Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Anti-obesity Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market segment by Application
Kids
Adults
Global Anti-obesity Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-obesity Drugs, market overview.
Chapter 2: Global Anti-obesity Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-obesity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-obesity Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-obesity Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-obesity Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 63090 million
|
| Forecast Market size by 2030 |
US$ 83320 million
|
| Growth Rate |
CAGR of 4.0% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
120 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-obesity Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-obesity Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-obesity Drugs Overall Market Size
2.1 Global Anti-obesity Drugs Market Size: 2023 VS 2030
2.2 Global Anti-obesity Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Anti-obesity Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Anti-obesity Drugs Players in Global Market
3.2 Top Global Anti-obesity Drugs Companies Ranked by Revenue
3.3 Global Anti-obesity Drugs Revenue by Companies
3.4 Global Anti-obesity Drugs Sales by Companies
3.5 Global Anti-obesity Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Anti-obesity Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Anti-obesity Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-obesity Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-obesity Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-obesity Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-obesity Drugs Market Size Markets, 2023 & 2030
4.1.2 Peripherally Acting Anti-obesity Drugs
4.1.3 Centrally Acting Anti-obesity Drugs
4.2 By Type - Global Anti-obesity Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-obesity Drugs Revenue, 2019-2024
4.2.2 By Type - Global Anti-obesity Drugs Revenue, 2025-2030
4.2.3 By Type - Global Anti-obesity Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Anti-obesity Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-obesity Drugs Sales, 2019-2024
4.3.2 By Type - Global Anti-obesity Drugs Sales, 2025-2030
4.3.3 By Type - Global Anti-obesity Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-obesity Drugs Market Size, 2023 & 2030
5.1.2 Kids
5.1.3 Adults
5.2 By Application - Global Anti-obesity Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-obesity Drugs Revenue, 2019-2024
5.2.2 By Application - Global Anti-obesity Drugs Revenue, 2025-2030
5.2.3 By Application - Global Anti-obesity Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Anti-obesity Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-obesity Drugs Sales, 2019-2024
5.3.2 By Application - Global Anti-obesity Drugs Sales, 2025-2030
5.3.3 By Application - Global Anti-obesity Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Anti-obesity Drugs Market Size, 2023 & 2030
6.2 By Region - Global Anti-obesity Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-obesity Drugs Revenue, 2019-2024
6.2.2 By Region - Global Anti-obesity Drugs Revenue, 2025-2030
6.2.3 By Region - Global Anti-obesity Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Anti-obesity Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-obesity Drugs Sales, 2019-2024
6.3.2 By Region - Global Anti-obesity Drugs Sales, 2025-2030
6.3.3 By Region - Global Anti-obesity Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Anti-obesity Drugs Revenue, 2019-2030
6.4.2 By Country - North America Anti-obesity Drugs Sales, 2019-2030
6.4.3 US Anti-obesity Drugs Market Size, 2019-2030
6.4.4 Canada Anti-obesity Drugs Market Size, 2019-2030
6.4.5 Mexico Anti-obesity Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Anti-obesity Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Anti-obesity Drugs Sales, 2019-2030
6.5.3 Germany Anti-obesity Drugs Market Size, 2019-2030
6.5.4 France Anti-obesity Drugs Market Size, 2019-2030
6.5.5 U.K. Anti-obesity Drugs Market Size, 2019-2030
6.5.6 Italy Anti-obesity Drugs Market Size, 2019-2030
6.5.7 Russia Anti-obesity Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Anti-obesity Drugs Market Size, 2019-2030
6.5.9 Benelux Anti-obesity Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Anti-obesity Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Anti-obesity Drugs Sales, 2019-2030
6.6.3 China Anti-obesity Drugs Market Size, 2019-2030
6.6.4 Japan Anti-obesity Drugs Market Size, 2019-2030
6.6.5 South Korea Anti-obesity Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Anti-obesity Drugs Market Size, 2019-2030
6.6.7 India Anti-obesity Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Anti-obesity Drugs Revenue, 2019-2030
6.7.2 By Country - South America Anti-obesity Drugs Sales, 2019-2030
6.7.3 Brazil Anti-obesity Drugs Market Size, 2019-2030
6.7.4 Argentina Anti-obesity Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-obesity Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Anti-obesity Drugs Sales, 2019-2030
6.8.3 Turkey Anti-obesity Drugs Market Size, 2019-2030
6.8.4 Israel Anti-obesity Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Anti-obesity Drugs Market Size, 2019-2030
6.8.6 UAE Anti-obesity Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Anti-obesity Drugs Major Product Offerings
7.1.4 Merck Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Novo Nordisk
7.2.1 Novo Nordisk Company Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Anti-obesity Drugs Major Product Offerings
7.2.4 Novo Nordisk Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Novo Nordisk Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Anti-obesity Drugs Major Product Offerings
7.3.4 Pfizer Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Pfizer Key News & Latest Developments
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Company Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Anti-obesity Drugs Major Product Offerings
7.4.4 Arena Pharmaceuticals Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Arena Pharmaceuticals Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Anti-obesity Drugs Major Product Offerings
7.5.4 Roche Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Roche Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Anti-obesity Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Company Summary
7.7.2 Orexigen Therapeutics Business Overview
7.7.3 Orexigen Therapeutics Anti-obesity Drugs Major Product Offerings
7.7.4 Orexigen Therapeutics Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Orexigen Therapeutics Key News & Latest Developments
7.8 Vivus
7.8.1 Vivus Company Summary
7.8.2 Vivus Business Overview
7.8.3 Vivus Anti-obesity Drugs Major Product Offerings
7.8.4 Vivus Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Vivus Key News & Latest Developments
7.9 Amylin
7.9.1 Amylin Company Summary
7.9.2 Amylin Business Overview
7.9.3 Amylin Anti-obesity Drugs Major Product Offerings
7.9.4 Amylin Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Amylin Key News & Latest Developments
7.10 Alizyme
7.10.1 Alizyme Company Summary
7.10.2 Alizyme Business Overview
7.10.3 Alizyme Anti-obesity Drugs Major Product Offerings
7.10.4 Alizyme Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Alizyme Key News & Latest Developments
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Company Summary
7.11.2 Boehringer Ingelheim Business Overview
7.11.3 Boehringer Ingelheim Anti-obesity Drugs Major Product Offerings
7.11.4 Boehringer Ingelheim Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Boehringer Ingelheim Key News & Latest Developments
7.12 Eisai
7.12.1 Eisai Company Summary
7.12.2 Eisai Business Overview
7.12.3 Eisai Anti-obesity Drugs Major Product Offerings
7.12.4 Eisai Anti-obesity Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Eisai Key News & Latest Developments
8 Global Anti-obesity Drugs Production Capacity, Analysis
8.1 Global Anti-obesity Drugs Production Capacity, 2019-2030
8.2 Anti-obesity Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-obesity Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-obesity Drugs Supply Chain Analysis
10.1 Anti-obesity Drugs Industry Value Chain
10.2 Anti-obesity Drugs Upstream Market
10.3 Anti-obesity Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-obesity Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-obesity Drugs in Global Market
Table 2. Top Anti-obesity Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Anti-obesity Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Anti-obesity Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Anti-obesity Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Anti-obesity Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Anti-obesity Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Anti-obesity Drugs Product Type
Table 9. List of Global Tier 1 Anti-obesity Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-obesity Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anti-obesity Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Anti-obesity Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Anti-obesity Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Anti-obesity Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Anti-obesity Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Anti-obesity Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Anti-obesity Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Anti-obesity Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Anti-obesity Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Anti-obesity Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Anti-obesity Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Anti-obesity Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Anti-obesity Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Anti-obesity Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Anti-obesity Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Anti-obesity Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Anti-obesity Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Anti-obesity Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Anti-obesity Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Anti-obesity Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Anti-obesity Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Anti-obesity Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Anti-obesity Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Anti-obesity Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Anti-obesity Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Anti-obesity Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Anti-obesity Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Anti-obesity Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Anti-obesity Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Anti-obesity Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Anti-obesity Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Anti-obesity Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Anti-obesity Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Anti-obesity Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Anti-obesity Drugs Sales, (K Units), 2025-2030
Table 46. Merck Company Summary
Table 47. Merck Anti-obesity Drugs Product Offerings
Table 48. Merck Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Merck Key News & Latest Developments
Table 50. Novo Nordisk Company Summary
Table 51. Novo Nordisk Anti-obesity Drugs Product Offerings
Table 52. Novo Nordisk Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Novo Nordisk Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Anti-obesity Drugs Product Offerings
Table 56. Pfizer Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. Arena Pharmaceuticals Company Summary
Table 59. Arena Pharmaceuticals Anti-obesity Drugs Product Offerings
Table 60. Arena Pharmaceuticals Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Arena Pharmaceuticals Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Anti-obesity Drugs Product Offerings
Table 64. Roche Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Roche Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Anti-obesity Drugs Product Offerings
Table 68. GlaxoSmithKline Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Orexigen Therapeutics Company Summary
Table 71. Orexigen Therapeutics Anti-obesity Drugs Product Offerings
Table 72. Orexigen Therapeutics Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Orexigen Therapeutics Key News & Latest Developments
Table 74. Vivus Company Summary
Table 75. Vivus Anti-obesity Drugs Product Offerings
Table 76. Vivus Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Vivus Key News & Latest Developments
Table 78. Amylin Company Summary
Table 79. Amylin Anti-obesity Drugs Product Offerings
Table 80. Amylin Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Amylin Key News & Latest Developments
Table 82. Alizyme Company Summary
Table 83. Alizyme Anti-obesity Drugs Product Offerings
Table 84. Alizyme Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Alizyme Key News & Latest Developments
Table 86. Boehringer Ingelheim Company Summary
Table 87. Boehringer Ingelheim Anti-obesity Drugs Product Offerings
Table 88. Boehringer Ingelheim Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. Boehringer Ingelheim Key News & Latest Developments
Table 90. Eisai Company Summary
Table 91. Eisai Anti-obesity Drugs Product Offerings
Table 92. Eisai Anti-obesity Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. Eisai Key News & Latest Developments
Table 94. Anti-obesity Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 95. Global Anti-obesity Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 96. Global Anti-obesity Drugs Production by Region, 2019-2024 (K Units)
Table 97. Global Anti-obesity Drugs Production by Region, 2025-2030 (K Units)
Table 98. Anti-obesity Drugs Market Opportunities & Trends in Global Market
Table 99. Anti-obesity Drugs Market Drivers in Global Market
Table 100. Anti-obesity Drugs Market Restraints in Global Market
Table 101. Anti-obesity Drugs Raw Materials
Table 102. Anti-obesity Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Anti-obesity Drugs Downstream
Table 104. Anti-obesity Drugs Downstream Clients in Global Market
Table 105. Anti-obesity Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-obesity Drugs Segment by Type in 2023
Figure 2. Anti-obesity Drugs Segment by Application in 2023
Figure 3. Global Anti-obesity Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anti-obesity Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anti-obesity Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Anti-obesity Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-obesity Drugs Revenue in 2023
Figure 9. By Type - Global Anti-obesity Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Anti-obesity Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Anti-obesity Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Anti-obesity Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Anti-obesity Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Anti-obesity Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 23. US Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 28. Germany Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 37. China Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Anti-obesity Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Anti-obesity Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Anti-obesity Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Anti-obesity Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Anti-obesity Drugs by Region, 2023 VS 2030
Figure 54. Anti-obesity Drugs Industry Value Chain
Figure 55. Marketing Channels
